Three Stocks Trading Below $50 Are Facing Difficulties, and Investors Are Advised to Seek Alternative Investments.

The investment landscape presents unique challenges, particularly for investors seeking growth opportunities. Often, mid-sized businesses with strong track records and significant potential for expansion fall into a difficult category. These companies, frequently carrying less risk than more speculative “penny stocks,” nevertheless grapple with volatility, a factor exacerbated by a lack of scale advantages compared to larger peers. This complexity prompts the need for discerning analysis, leading to the creation of StockStory–a resource designed to differentiate robust companies from those facing persistent difficulties. This article will examine three stocks trading under $50—Astec (ASTE), Fortrea (FTRE), and Employers Holdings (EIG)—presenting reasoned arguments for avoiding them and suggesting alternative investment considerations.

Astec (ASTE)

Astec, traded at $45.65, specializes in machinery and equipment for road construction, raw material processing, and concrete production. The company’s origins lie in inventing the first double-barrel hot-mix asphalt plant. However, several factors contribute to our reservations regarding Astec’s investment potential. A crucial concern is the need to reconsider its product roadmap and go-to-market strategy, as evidenced by an average backlog decline of 28.2% over the preceding two years. This highlights a potential failure to effectively translate market demand into sales. Furthermore, the company operates with a relatively low gross margin (23.9%) which creates a critical reliance on higher sales volumes to offset elevated input costs. This cash-burning tendency raises questions about the company’s capacity for sustained, shareholder-friendly value generation. Currently, the stock’s valuation reflects a 14.6x forward P/E ratio.

Fortrea (FTRE)

Fortrea, valued at $17.70, was created in 2023 as a spin-off from Labcorp, and currently focuses exclusively on clinical research services. As a contract research organization (CRO), Fortrea assists pharmaceutical, biotech, and medical device companies through clinical trials and related support services. Despite its specialized focus, Fortrea has experienced challenges that warrant caution. For the past four years, annual sales declines of 2.6% indicate difficulties in effectively connecting its products and services with market demand. Compounding this issue is the diminishing returns on capital, especially considering its relatively low starting point – suggesting current management strategies are not adequately performing. A key indicator of concern is the 6x net-debt-to-EBITDA ratio, signaling overleveraging and increasing the probability of shareholder dilution if unforeseen economic circumstances arise. The company’s current valuation stands at 26.5x forward P/E.

Employers Holdings (EIG)

Employers Holdings, trading at $42.92, operates as a specialist provider of workers’ compensation insurance, concentrating primarily on small and select businesses within low-to-medium hazard industries across the United States, with a strong presence in Nevada and California (45% of its premiums originate in California). The company’s assessment reflects a cautious outlook. While demonstrating 3.3% annualized net premiums earned growth over the last two years, this growth lagged behind its peer group of insurance companies. Operational inefficiencies have also been a factor; costs have risen at a pace exceeding revenue growth over the same period, leading to a deterioration in the combined ratio by 10.9 percentage points. Incremental sales over the past five years have been less profitable, with earnings per share falling by 8.3% annually, while revenue has increased. This translates to a 0.9x forward P/B valuation, reflecting the complexities within the current trading environment.

Investment Alternatives and Strategic Considerations

The market’s substantial gains this year, concentrated within just four S&P 500 components, underscore the importance of diversified investment strategies. While names like Nvidia have delivered exceptional returns, concentrating investments in these popular stocks exposes investors to significant risk. Smart investors are turning their attention to high-quality stocks – those that have generated market-beating returns – and are willing to pay a fraction of the price. StockStory highlights a carefully curated list of “High Quality” stocks – a group that has generated a market-beating return of 244% over the last five years (as of June 30, 2025). Stocks that made our list in 2020 – including Nvidia (+1,326%) – along with under-the-radar businesses, such as Tecnoglass (+1,754%) – present compelling opportunities for discerning investors. Utilizing StockStory offers a free resource to locate your next significant winner.